Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia

• Colin Vercueil,
• Lauriane Eberst,
• Catherine Humbrecht,
• Luc-Matthieu Fornecker

Affiliations

Colin Vercueil

1 Oncology Department, Institut de Cancérologie Strasbourg Europe, France

Lauriane Eberst

1 Oncology Department, Institut de Cancérologie Strasbourg Europe, France

Catherine Humbrecht

2 Etablissement Français du Sang, Strasbourg, France

Luc-Matthieu Fornecker

3 Hematology Department, Institut de Cancérologie Strasbourg Europe, France